Glenmark Nepal

Glenmark Nepal

Pharmaceutical Manufacturing

A new way for a new world

About us

Glenmark was founded with a vision to emerge as a leading integrated research-based, global pharmaceutical company. Our branded generics business has a significant presence in markets across emerging economies including Nepal. The generics business services the requirements of developed markets like US and Western Europe. Our API business sells products in over 65 countries including the US, various countries in the EU, South America and India. With 14 manufacturing facilities and 4 R&D centers spanning across GPL and GLS, dedicated to the goal of enriching lives across the globe we believe that the real force behind our continued successes are dedicated employees from across 60 nationalities, committed to creating ‘A new way for a new world’.

Website
www.glenmarkpharma.com
Industry
Pharmaceutical Manufacturing
Company size
10,001+ employees
Headquarters
Kathmandu
Type
Public Company

Locations

Updates

  • View organization page for Glenmark Nepal, graphic

    74 followers

    As per WHO Nepal, Nearly 1 in 4 people in Nepal suffer from hypertension, and less than 5% of hypertension patients have the condition under control. Screening asymptomatic individuals is important to identify undiagnosed hypertension. However, there are certain gray areas in screening for hypertension and the lack of national guidelines for effective screening of hypertension led to the formulation of this consensus. 42 experts from cardiology and allied fields discussed the current evidence and formulated a unified consensus to guide primary care physicians in the effective screening of hypertension in asymptomatic individuals. Consensus conclusion: 1. In #Nepal, hypertension diagnosis is mostly limited to clinics or hospitals with limited active ongoing community screening programs. This leads to unawareness, underdiagnosis, undertreatment, and thereby poor control of hypertension. 2. Through this consensus, we identify that hypertension screening undertaken in adults from the age of 18 years can be effective for early diagnosis and interventions that will help reduce the community burden of CVDs. 3. Moreover, regular rescreening as per current blood pressure level can aid in the early detection of hypertension or potentially uncontrolled hypertension. 4. Hypertension screening is cost-effective even in resource-poor settings and should be implemented adequately to identify the disease at the earliest with the involvement of all healthcare stakeholders in the community. Glenmark Pharmaceuticals being leaders in #Hypertension therapy took initiatives to spread awareness on early diagnosis in Nepal under “Livemore with BP in control” and “Take charge@18” initiatives. I.Livemore emphasises organ protection with early diagnosis and management of hypertension, there by living life more II.Take charge@18 emphasises the right age to screen for blood pressure in Nepal is 18 years.

  • View organization page for Glenmark Nepal, graphic

    74 followers

    On this #WorldAsthmaDay, let us come together to raise awareness about asthma. Asthma can impact individuals daily lives in various ways, affecting their physical, mental and emotional health. This year, GINA(Global Initiative for Asthma) emphasises the need to empower people with asthma with the appropriate education to manage their disease, and to recognise when to seek medical help. Under the #Glenmark’s initiative of “let me also breathe”, Health care professionals across #Nepal actively participated in increasing awareness about the effective management of asthma. Asthma is manageable and it should not prevent anyone from achieving their goals.🎯 Siddharth Pradhan Uttarwar Pruthviraj

    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
    • No alternative text description for this image
      +2

Similar pages